Literature DB >> 14758070

Galectin-1: a bifunctional regulator of cellular proliferation.

Ken Scott1, Cristina Weinberg.   

Abstract

Galectin-1 has demonstrated a diverse range of activities in relation to cell survival and proliferation. In different circumstances, it acts as a mitogen, as an inhibitor of cell proliferation, and as a promoter of cellular apoptosis. Many of these activities, particularly the mitogenic and apoptotic responses, follow from the interaction of galectin-1 with cell-surface beta-galactoside ligands, but there is increasing evidence for protein-protein interactions involving galectin-1, and for a beta-galactoside-independent cytostatic mechanism. The bifunctional nature of galectin-1, in conjunction with other experimental variables, makes it difficult to assess the overall outcomes and significance of the growth-regulatory actions in many previous investigations. There is thus a need for well-defined experimental cross-correlation of observations, for which specific loss-of-function galectin-1 mutants will be invaluable. Unsurprisingly, in view of this background, the interpretation of the actions of galectin-1 in developmental situations, both normal and neoplastic, is often very complex.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 14758070     DOI: 10.1023/B:GLYC.0000014076.43288.89

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  103 in total

1.  FosB gene products trigger cell proliferation and morphological alteration with an increased expression of a novel processed form of galectin-1 in the rat 3Y1 embryo cell line.

Authors:  Tomoko Nishioka; Kunihiko Sakumi; Tomofumi Miura; Kazuki Tahara; Hidenori Horie; Toshihiko Kadoya; Yusaku Nakabeppu
Journal:  J Biochem       Date:  2002-05       Impact factor: 3.387

2.  Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma.

Authors:  D K Hsu; C A Dowling; K C Jeng; J T Chen; R Y Yang; F T Liu
Journal:  Int J Cancer       Date:  1999-05-17       Impact factor: 7.396

3.  The levels of expression of galectin-1, galectin-3, and the Thomsen-Friedenreich antigen and their binding sites decrease as clinical aggressiveness increases in head and neck cancers.

Authors:  G Choufani; N Nagy; S Saussez; H Marchant; P Bisschop; M Burchert; A Danguy; S Louryan; I Salmon; H J Gabius; R Kiss; S Hassid
Journal:  Cancer       Date:  1999-12-01       Impact factor: 6.860

4.  Augmented expression of peroxiredoxin I in lung cancer.

Authors:  J W Chang; H B Jeon; J H Lee; J S Yoo; J S Chun; J H Kim; Y J Yoo
Journal:  Biochem Biophys Res Commun       Date:  2001-11-30       Impact factor: 3.575

5.  Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting.

Authors:  Nathalie Nagy; Hugues Legendre; Olivier Engels; Sabine André; Herbert Kaltner; Kojiro Wasano; Yehiel Zick; Jean-Claude Pector; Christine Decaestecker; Hans-Joachim Gabius; Isabelle Salmon; Robert Kiss
Journal:  Cancer       Date:  2003-04-15       Impact factor: 6.860

6.  Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures.

Authors:  H Lahm; S André; A Hoeflich; J R Fischer; B Sordat; H Kaltner; E Wolf; H J Gabius
Journal:  J Cancer Res Clin Oncol       Date:  2001       Impact factor: 4.553

Review 7.  Cell surface glycoconjugates as onco-differentiation markers in hematopoietic cells.

Authors:  M Fukuda
Journal:  Biochim Biophys Acta       Date:  1985

8.  Galectin 1 modulates attachment, spreading and migration of cultured vascular smooth muscle cells via interactions with cellular receptors and components of extracellular matrix.

Authors:  E P Moiseeva; E L Spring; J H Baron; D P de Bono
Journal:  J Vasc Res       Date:  1999 Jan-Feb       Impact factor: 1.934

9.  Beta-galactoside-binding protein (beta GBP) alters the cell cycle, up-regulates expression of the alpha- and beta-chains of the IFN-gamma receptor, and triggers IFN-gamma-mediated apoptosis of activated human T lymphocytes.

Authors:  A Allione; V Wells; G Forni; L Mallucci; F Novelli
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

10.  Identification of an autocrine negative growth factor: mouse beta-galactoside-binding protein is a cytostatic factor and cell growth regulator.

Authors:  V Wells; L Mallucci
Journal:  Cell       Date:  1991-01-11       Impact factor: 41.582

View more
  34 in total

Review 1.  Introduction to galectins.

Authors:  Hakon Leffler; Susanne Carlsson; Maria Hedlund; Yuning Qian; Francoise Poirier
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

2.  Galectin-1, -3, -7 expressions in congenital and acquired pediatric cholesteatomas compared to external auditory canal skin.

Authors:  Marc Vander Ghinst; Myriam Remmelink; Anne-Laure Mansbach; Sergio Hassid; Georges Choufani
Journal:  Clin Exp Otorhinolaryngol       Date:  2012-06-12       Impact factor: 3.372

3.  Galectin-1-mediated biochemical controls of melanoma and glioma aggressive behavior.

Authors:  Florence Lefranc; Véronique Mathieu; Robert Kiss
Journal:  World J Biol Chem       Date:  2011-09-26

4.  Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy.

Authors:  Victor L J L Thijssen; Ruben Postel; Ricardo J M G E Brandwijk; Ruud P M Dings; Irina Nesmelova; Sietske Satijn; Nicole Verhofstad; Yusaku Nakabeppu; Linda G Baum; Jeroen Bakkers; Kevin H Mayo; Françoise Poirier; Arjan W Griffioen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

5.  Morphine and galectin-1 modulate HIV-1 infection of human monocyte-derived macrophages.

Authors:  Jessica L Reynolds; Wing Cheung Law; Supriya D Mahajan; Ravikumar Aalinkeel; Bindukumar Nair; Donald E Sykes; Manoj J Mammen; Ken-Tye Yong; Rui Hui; Paras N Prasad; Stanley A Schwartz
Journal:  J Immunol       Date:  2012-03-19       Impact factor: 5.422

Review 6.  How galectins have become multifunctional proteins.

Authors:  Gabriel García Caballero; Herbert Kaltner; Tanja J Kutzner; Anna-Kristin Ludwig; Joachim C Manning; Sebastian Schmidt; Fred Sinowatz; Hans-Joachim Gabius
Journal:  Histol Histopathol       Date:  2020-01-10       Impact factor: 2.303

7.  The Galectin-1 level in serum as a novel marker for stress.

Authors:  Mayuko Iwamoto; Chiho Taguchi; Kenichi Sasaguri; Kin-ya Kubo; Hidenori Horie; Toshiharu Yamamoto; Minoru Onozuka; Sadao Sato; Toshihiko Kadoya
Journal:  Glycoconj J       Date:  2010-05       Impact factor: 2.916

8.  Proteomic analysis of rosiglitazone and guggulsterone treated 3T3-L1 preadipocytes.

Authors:  Pooja Pal; Jitendra K Kanaujiya; Savita Lochab; Shashi B Tripathi; Sabyasachi Sanyal; Gerhard Behre; Arun K Trivedi
Journal:  Mol Cell Biochem       Date:  2012-12-30       Impact factor: 3.396

9.  Dissociation of the carbohydrate-binding and splicing activities of galectin-1.

Authors:  Patricia G Voss; Richard M Gray; Seth W Dickey; Weizhong Wang; Jung W Park; Ken-Ichi Kasai; Jun Hirabayashi; Ronald J Patterson; John L Wang
Journal:  Arch Biochem Biophys       Date:  2008-07-16       Impact factor: 4.013

10.  Nuclear translocation of immulectin-3 stimulates hemocyte proliferation.

Authors:  Erjun Ling; Jingqun Ao; Xiao-Qiang Yu
Journal:  Mol Immunol       Date:  2008-02-20       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.